Autopsy report · NCT03009799

Efficacy and Safety of Iota-Carrageenan Eye Drops (NCX-4240)

“Study stopped following management decision”

The sponsor’s own words in the registry.

Life of this trial

• Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.

Vital statistics

Status

Withdrawn

Phase

Phase 2

Sponsor

NicOx

Sponsor type

Industry

Conditions

Adenoviral Conjunctivitis

Interventions

Iota-Carrageenan; Carmellose

Participants

0

Sites

1

Countries

Spain

Trials that died the same way

• How Can a Driving Virtual Reality Tool Improve Quality of Life and Social Autonomy in Patients With Schizophrenia
  “Decision to stop the study” (82% match in meaning)
• An Efficacy and Safety of Flomoxef Versus Cefepime in the Treatment of Participants With Urinary Tract Infections
  “Study was prematurely terminated due to administrative and strategic reasons” (81% match in meaning)
• A FDG-PET Study of AGN-242071 Added to Standard-of-Care (Donepezil ± Memantine) for the Treatment of Participants With Mild to Moderate Alzheimer's Disease
  “Business decision to stop the study.” (80% match in meaning)
• Plaque Removal Versus Open Bypass Surgery For Critical Limb Ischemia
  “Company decision to halt study” (80% match in meaning)
• Maxi-Analgesic Osteoarthritis (OA) Study
  “The study was withdrawn for administrative reason” (78% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.